Dr. Tom McDonnell:

There are always concerns with lobbying of any type. There are questions as to whether it will affect the behaviour of people in the hospital as regards prescribing certain types of drugs or whatever it might be. However, I must again confess that this is not my area of expertise so there is not really much that I can add. I certainly think there would be value in having that type of input, provided it was in very specific research-related areas, for example. I do not particularly see an issue with that.